Search Results 1321-1330 of 18292 for Topical

1. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Inhaled and topical corticosteroids and mineralocorticoids are allowed. Administration of a live, attenuated vaccine within 30 days before first dose of ...

2. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...

3. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

   The chronic use of topical, inhaled, and locally injected steroids is permitted 15. Subjects who have received treatment with anthracyclines with a ...

4. Fenofibrate for Prevention of DR Worsening - Mayo Clinic

   Evidence of uncontrolled glaucoma (intraocular pressure must be <30, with no more than one topical glaucoma medication, and no documented glaucomatous field ...

5. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Current use of oral corticosteroids, with the exception of inhaled or topical steroids. Dexamethasone will be given only in combination with bortezomib on ...

6. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone ...

7. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Intranasal, inhaled, topical steroids, or local steroid injections (e.g., intra-articular injection);; Systemic corticosteroids at doses not to exceed 10 mg ...

8. SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy - Mayo Clinic

   Inhaled or topical steroids, and adrenal replacement doses > 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.

9. Oral lichen planus - Diagnosis and treatment - Mayo Clinic

   This ongoing inflammatory condition results in white, lacy patches or red, swollen tissues or open sores inside your mouth that may cause burning or pain.

10. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Physiologic replacement, topical, intranasal, and inhaled steroids are permitted;; Anti-MM antibody within 14 days before leukapheresis;; Alkylating agents ...